The value of biomarkers as diagnostic tool in obstructive sleepapnea

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON24299

Enrollment

400

Registered

2020-01-15

Start date

2020-06-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive sleepapnea

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: - 18 years and older - Diagnosed with OSA confirmed by a PSG (AHI=5 events per hour)

Exclusion criteria

Exclusion criteria: - Central sleep apnea syndrome (>50% of central apneas) - Inability to provide informed consent

Design outcomes

Primary

Measure	Time frame
Changes in the selected biomarkers before and after OSA treatment	—

Secondary

Measure	Time frame
Changes in AHI, ODI and subjective outcomes correlated to changes in biomarkers	—

Contacts

Public ContactPien Bosschieter

OLVG, locatie west

p.f.n.bosschieter@olvg.nl020-4807423

Outcome results